News

Dying patients may feel burdened by suffering and loss of dignity, which is why this doctor argues in favor of medical aid in dying.

“…The light of a new year.”

Did psychiatrists collectively do the right thing in these situations…?

The first phase 3 clinical trial of CTx-1301 for the treatment of ADHD has begun.

How can we harness the technologies of today—and tomorrow—to expand access to mental health services?

Why can’t humans get along? An expert explores the biological underpinnings of our dualistic thinking.

Here’s why we need to do the hard work of making changes that help achieve our goals.

Is New York City acting with empathy towards the homeless?

Faced with extensive suffering or loss of dignity in the context of a terminal illness, different individuals will make different choices…

We remain challenged to improve treatments and outcomes in schizophrenia. Explore the latest options.

Smoking and drinking (caffeine): Researchers analyzed caffeine intake and levels in smokers with schizophrenia and bipolar disorder.

Are you carrying emotional baggage from 2022?

New work for the new year…

From new advances in the treatment of postpartum depression to digital therapeutics for the treatment of ADHD in children, here are highlights from the week in Psychiatric Times.

An accurate diagnosis?

Revisiting the CME articles featured in Psychiatric Times in 2022.

What is the most hopeful holiday around the world—and why is it more important this year than ever?

The experts weighed in on a wide variety of psychiatric issues for the December 2022 issue of Psychiatric Times.

That's one way to handle family drama...

Even when facing the most difficult opponents, it's possible to win a positive outcome.

VR-based training may help improve social cognition and functioning in patients with schizophrenia.

From current treatments for cannabis use disorder to new possibilities for the treatment of dementia, here are highlights from the week in Psychiatric Times.

A psychiatrist reflects on his story...

'Tis the season...

“We hold on to the promise because it continues to sustain us… and me.”

While there are no FDA-approved medications available for CUD, some studies show potential off-label utility in mitigating withdrawal and maintaining abstinence. Learn more in this CME article.

How can we open our minds?

"Dementia is a mental health condition that can make or break families. Remember that behind the difficult behavior is your loved one."

Instead of figuring out ways to help people die, what if we devoted our energy to helping them live, even and especially if they are dying?

How can we, as clinicians, humanize our field and provide better care for our patients?